GSK3B and renal carcinoma: Accordingly, the downregulation of GSK3β inhibits proliferation and enhances apoptotic cell death in chronic lymphocytic leukemia B cells, renal cancer cells, pancreatic cancer cells, and colon cancer cells [19], [20].